The US Food and Drug Administration (FDA) attracted considerable attention when it sent a Warning Letter that raised questions about why so many out-of-specification tablets are still distributed despite strict regulations and modern technology. In a White Paper Fette Compacting investigates the possible causes and offers advice on the optimum use of tablet presses.
In recent years, the Pharma industry has found itself at cross-roads, its base of renewal eroding fast in the face of several major challenges. In parallel to these challenges however, new opportunities have emerged for the industry: new markets and consumers, new technologies, and more efficient operations. Ulf Schrader of McKinsey examines and evaluates this situation.

India is one of the most rapidly growing markets for medications. In terms of production, it is already home to the world’s second-largest pharmaceutical industry. In the Indian state of Goa, which is in the west of the country, Fette compacting, a subsidiary of the LMT Group, has now opened a competence center for tablet manufacture.

Producing effervescent tablets is a tricky business – the tablets quickly stick to the punches in the tablet press. Argentinian company Roemmers Laboratories was very aware of this when it planned the set-up of a production line for pharmaceutical effervescent tablets.

In July Fette Compacting India commenced training courses at the new competence centre in Goa with a two-day customer event. With the programme the company set new standards in India for consulting and support services in the tableting sector, particularly in the OEE field.

A world premiere, numerous trade visitors from all over the world, a well-attended press conference and a customer event which set standards – there was never a dull moment at the Fette Compacting Achema stand. A brief review of an eventful trade fair.